Medicaid Program; Prohibition on Federal Medicaid and Children’s Health Insurance Program Funding for Sex-Rejecting Procedures Furnished to Children

Key claim: Federal Medicaid and CHIP will no longer pay for sex-rejecting procedures for minors, with only a limited wind-down for children already on cross-sex hormones.

Abstract

(Rule · Health and Human Services Department, Centers for Medicare & Medicaid Services) This final rule requires that a State Medicaid plan must provide that the Medicaid agency will not make payment under the plan for sex-rejecting procedures for children under 18, and prohibits the use of Federal Medicaid dollars to fund sex-rejecting procedures for individuals under the age of 18. In addition, this final rule requires that a separate State Children’s Health Insurance Program (CHIP) plan must provide that the CHIP agency will not make payment under the plan for sex-rejecting procedures for children under 19, and prohibits the use of Federal CHIP dollars to fund sex-rejecting procedures for individuals under the age of 19. For Medicaid and CHIP beneficiaries who are actively receiving cross-sex hormone therapy, State Medicaid and CHIP agencies may continue to claim Federal Financial Participation for those hormone therapy medications for a period of up to 6 months from the effective date of this final rule.

Why this matters

A nationwide final rule removing federal Medicaid and CHIP payment for sex-rejecting procedures for minors materially changes what state programs can cover for enrolled children and creates a limited transition period for those already on cross-sex hormones. Because Medicaid and CHIP are primary insurers for many low-income youth, the practical effect is a sharp reduction in access regardless of state policy, while contested clinical and civil-rights questions about minors’ gender-related care remain live in courts and legislatures.

Source

Link